(Press-News.org) SALT LAKE CITY — Researchers at the Intermountain Medical Center Heart Institute have, for the first time ever, made a connection between tiny genetic molecules called microRNAs and the imminent threat of a heart attack, according to a new study.
The findings are an important first step toward developing a method for predicting heart attacks in people who show no outward signs, but may be at great risk of having a heart attack. The research group will present study results today (March 25) at the American College of Cardiology's 61st Annual Scientific Session in Chicago.
"About half of all heart attacks occur in patients with no previous signs of heart disease. The heart attack is a surprise, and very often it's deadly," says Jeffrey L. Anderson, MD, chief of cardiovascular research at the Intermountain Medical Center Heart Institute and one of the study's authors. "This project has a lot of promise in helping us develop a way to identify these patients who don't show any obvious signs but are at imminent risk of suffering a heart attack."
The research group from Intermountain Medical Center, the flagship facility for the Intermountain Healthcare system, examined blood samples for the presence of six microRNA molecules that had previously been identified in patients after a heart attack. These genetic structures serve as an "on-off switch" for regulating the expression of a host of genes. When their levels drop, the genes they help to control are no longer regulated and can go "rogue."
The blood samples came from 85 patients who were sorted into four groups:
Pre-heart attack patients, whose blood was drawn one to seven days before a heart attack
Post-heart attack patients, whose blood was drawn within 36 hours after a heart attack
Patients with cardiac problems, but no heart attack within one year before or after blood sample collection
Healthy patients with no cardiac problems
"We found that three of those six microRNA molecules were present in significantly lower levels in patients who had a heart attack within the next seven days compared to the two groups who didn't have a heart attack," says Oxana Galenko, who holds a doctorate in biomedical science and is lead author of the study.
The researchers believe the low levels of microRNA and the resulting genetic dysfunction may herald the heart attack. The three microRNAs are known as miR-122, miR-145, and miR-375.
"We don't know exactly which genes are controlled by these microRNAs, but this study gives us a good starting point for looking more deeply into the ways they influence the heart," says John Carlquist, PhD, director of Intermountain Healthcare's Cardiovascular Molecular and Genetic Laboratory at LDS Hospital and one of the study's authors.
The researchers envision a day in the not-too-distant future when a patient with cardiac risk factors does regular blood testing to watch for signs of imminent heart attack. Developments in nanotechnology one day may make it possible to continuously monitor an individual's blood for changes in these markers and alert a physician at any sign of danger.
The group says this study was possible only at Intermountain Healthcare, which helped to pioneer computerized health data collection in the 1950s and continues today. Intermountain is home to the world's largest cardiovascular DNA and plasma bank repository, which includes samples from more than 20,000 consenting patients. Combining these resources allowed researchers to search medical records for patients who had a heart attack and also had a frozen blood sample in storage that was drawn in the days before the heart attack.
"Because of this trove of patient records and specimens, we're uniquely equipped to do a study like this," says Dr. Carlquist.
The group will continue their research into microRNAs and heart attack with another study looking at a larger sample of patients, says Dr. Galenko.
###
Members of the research team include: Oxana Galenko, Tyler Miyawaki, Staci Gunter, Stacey Knight, John Carlquist and Jeffrey L. Anderson.
END
BOSTON, MA—According to a new study by researchers at Brigham and Women's Hospital (BWH), men with type 2 diabetes treated with insulin without a history of cardiovascular disease (CVD) were at higher risk for major cardiovascular events (e.g., death, heart attack, stroke) compared with men who had a history of CVD.
The study is being presented at the American College of Cardiology 2012 Annual Scientific Session, March 24 to 26 in Chicago.
Using data from the global REACH Registry, researchers evaluated the magnitude of risk of diabetes mellitus on cardiovascular ...
CHICAGO -- A population-wide community and clinical prevention program involving 10,000 adults meaningfully reduced the cardiovascular (CV) risk profile among a substantial portion of the population as indicated by those participating in screenings. Findings also indicate the level of improvements differ by gender for specific cardiovascular risk factors. The results will be presented March 25 at the 61st annual American College of Cardiology (ACC) scientific session.
Hearts Beat Back: The Heart of New Ulm Project (HONU) is a demonstration project aimed at reducing heart ...
CHICAGO—Selected patients 90 years and older who experience an acute heart attack, or ST-elevation myocardial infarction (STEMI), have reasonable outcomes with coronary stenting, and should be considered for reperfusion therapy, based on a scientific poster being presented at the 61st annual American College of Cardiology (ACC) scientific session.
Current STEMI guidelines do not specifically address age-related reperfusion decisions, even number though the number of people over 90 years old in the U.S. is expected to quadruple by 2050.
"Cardiologists are a little ...
As the Dallas Arts District continues to grow and reshape northern downtown Dallas, the new Dallas Marriott City Center introduces Centric, the latest addition to the restaurant scene - a hotspot within walking distance of the AT&T Performing Arts Center, the Meyerson Symphony Center, the Dallas Museum of Art and more.
Located at 650 N. Pearl St. at the Plaza of the Americas, the upscale restaurant features a Texas eclectic menu by Executive Chef Yoni Heredia, with fresh ingredients sourced from local producers including Dallas' Mozzarella Company, Jimmy's Food Store ...
CHICAGO—There is an imbalance between the rapid growth of cardiac catheterization laboratories, which provide percutaneous coronary intervention (PCI) procedures, relative to the growth in the overall U.S. population, as well as patients who experience an acute heart attack, or ST-elevation myocardial infarction (STEMI), according to a study presented March 25 at the 61st annual American College of Cardiology (ACC) scientific session.
PCI is the preferred treatment strategy for patients who undergo STEMI. However, distance and access to PCI remains a determining factor ...
Male high school athletes' ability to recognize and intervene to stop dating violence -- the physical, sexual and emotional aggression prevalent in adolescent romantic relationships -- is improved with the intervention of some of the most important role models in young men's lives: their coaches.
A new study conducted in Sacramento, Calif., led by UC Davis researchers has found that a structured program delivered by coaches, called "Coaching Boys into Men," is effective for discouraging adolescent dating violence. The research is published online today in the Journal ...
Researchers at Queen Mary, University of London have identified a new protein that makes pancreatic cancer cells less 'sticky' and therefore less able to attach to and invade other tissue.
The protein, known as S100PBP, does this by suppressing a second protein called cathepsin Z. The research team has shown that cathepsin Z makes pancreatic cancer cells sticky, allowing them to spread to their surrounding environment. Prior to this study nothing was known about the function of S100PBP in the body or the role that cathepsin Z plays in pancreactic cancer.
The findings, ...
A new study has found that very few young women with cancer take steps to preserve their fertility while undergoing cancer therapy. Also, certain groups of young women are more likely to do so than others. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study indicates that efforts are needed to provide counseling on fertility preservation in reproductive-aged women diagnosed with cancer.
More than 120,000 women under 50 years of age are diagnosed with cancer each year in the United States. As cancer survival rates are improving, ...
Los Angeles (Embargoed Until 12:01 a.m. EDT on March 26, 2012) –Cedars-Sinai researchers have determined that two prevalent drug therapies – rifaximin and lubiprostone – offer some of the best options for treating irritable bowel syndrome, a widespread disorder that affects up to one in five Americans. The findings, based on an analysis of more than two dozen large-scale clinical trials, are contained in a peer-reviewed study published online by The American Journal of Medicine and set to appear in the publication's April print edition.
Patients with irritable bowel syndrome ...
Optex, Inc. and Milestone Systems today announced that Optex perimeter security products will be fully integrated with Milestone XProtect Corporate and XProtect Enterprise IP video management platforms. The result will provide features and benefits unprecedented within the security industry for outdoor perimeter applications.
Optex detection products will be integrated fully into the XProtect platform through add-on Milestone device packs available summer 2012. Device packs will be available for:
Redscan Laser-Scan Detectors that identify moving objects' size, speed, ...
